(Q42541257)

2 November 2017

Effect of hypolipidemic drugs on key enzyme activities related to lipid metabolism in normolipidemic rabbits (English)

1 reference

2 November 2017

1

1 reference

2 November 2017

Verd JC

2

1 reference

2 November 2017

Díaz C

3

1 reference

2 November 2017

Hernández G

4

1 reference

2 November 2017

Adzet T

5

1 reference

2 November 2017

Sánchez RM

6

1 reference

2 November 2017

Laguna JC

7

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

European Journal of Pharmacology

2 November 2017

1 reference

2 November 2017

347

1 reference

2 November 2017

2-3

1 reference

2 November 2017

283-291

1 reference

Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

In vivo regulation of hepatic lipase activity and mRNA levels by diets which modify cholesterol influx to the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7 alpha-hydroxylation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Stimulatory effect of mevinolin on rat liver phosphatidic acid phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Lysophosphatidylcholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine inhibit the CDP-choline pathway of phosphatidylcholine synthesis at the CTP:phosphocholine cytidylyltransferase step.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Management of primary hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Effect of pravastatin on fatty acid profile of low density lipoprotein in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Studies on rat liver phosphatidate phosphohydrolase and plasma lipids: effect of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Effects of MK-733 (simvastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on intestinal acylcoenzyme A:cholesterol acyltransferase activity in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Cholesterol is required for the secretion of the very-low-density lipoprotein: in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Species differences in hepatic peroxisome proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

An enzymatic explanation of the differential effects of oleate and gemfibrozil on cultured hepatocyte triacylglycerol and phosphatidylcholine biosynthesis and secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Inhibition of rat liver microsomal fatty acid chain elongation by gemfibrozil in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Effect of simvastatin (MK-733) on plasma triacylglycerol levels in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rat. off

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Effect of gemfibrozil on adipose tissue and muscle lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Bezafibrate fails to directly modulate HMG-CoA reductase or LDL catabolism in human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Lovastatin and gemfibrozil in the treatment of type 2a and type 2b hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients. Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Intralipid administration induces a lipoprotein lipase-like activity in the livers of starved adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Regulation of bile acid synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Choline-phosphate cytidylyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Simvastatin and bezafibrate: effects on serum lipoproteins and lecithin: cholesterol acyltransferase activity in familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

Diacylglycerol acyltransferase and monoacylglycerol acyltransferase from liver and intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900096-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00096-X

1 reference

2 November 2017

1 reference